0 18

Cited 0 times in

Cited 0 times in

Plain language summary of TASUKI-52: A study looking at nivolumab plus platinum chemotherapy and bevacizumab as a combined treatment for people with advanced or recurrent nonsquamous non-small cell lung cancer (NSCLC)

Authors
 Sugawara, Shunichi  ;  Lee, Jong-Seok  ;  Kang, Jin-Hyoung  ;  Kim, Hye Ryun  ;  Inui, Naoki  ;  Hida, Toyoaki  ;  Lee, Ki Hyeong  ;  Yoshida, Tatsuya  ;  Tanaka, Hiroshi  ;  Yang, Cheng-Ta  ;  Inoue, Takako  ;  Nishio, Makoto  ;  Goto, Yasushi  ;  Tamura, Tomohide  ;  Yamamoto, Nobuyuki  ;  Yu, Chong-Jen  ;  Akamatsu, Hiroaki  ;  Takahashi, Shigeru  ;  Nakagawa, Kazuhiko 
Citation
 FUTURE ONCOLOGY, Vol.22(4) : 399-416, 2026-02 
Journal Title
FUTURE ONCOLOGY
ISSN
 1479-6694 
Issue Date
2026-02
Keywords
PD-1 ; randomized controlled trial ; PD-L1 ; non-squamous non-small cell lung cancer ; Asian
Full Text
https://www.tandfonline.com/doi/abs/10.1080/14796694.2026.2617855
DOI
10.1080/14796694.2026.2617855
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Hye Ryun(김혜련) ORCID logo https://orcid.org/0000-0002-1842-9070
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/211274
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links